Details
Stereochemistry | ACHIRAL |
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C=O
InChI
InChIKey=CURLTUGMZLYLDI-UHFFFAOYSA-N
InChI=1S/CO2/c2-1-3
Molecular Formula | CO2 |
Molecular Weight | 44.0095 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Carbon dioxide is a colorless gas occurring naturally in Earth's atmosphere. Carbon dioxide is a primary carbon source for life on Earth. It is produced by all aerobic organisms during metabolism of carbohydrates and lipids. Carbon dioxide is used in food industry as an acidity regulator and for production of carbonated soft drinks and soda water. In medicine, carbon dioxide is commonly used as an insufflation gas for minimally invasive surgery (laparoscopy, endoscopy, and arthroscopy) to enlarge and stabilize body cavities to provide better visibility of the surgical area. A mixture of carbon dioxide and oxygen is used for stimulation of breathing after apnea, in anesthetic procedures to increase the depth of respiration, to facilitate blind intubations in anesthetic practice.
CNS Activity
Sources: https://www.boconline.co.uk/internet.lg.lg.gbr/en/images/medical_carbon_dioxide410_56027.pdf?v=2.0
Curator's Comment: Carbon dioxide is naturally produced in all tissues.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseCarbon dioxide is used to stimulate respiration after a period of apnoea |
|||
Primary | Unknown Approved UseCarbon dioxide is used in chronic respiratory obstruction after it has been relieved |
|||
Palliative | Unknown Approved UseCarbon dioxide is used to increase cerebral blood flow in arteriosclerotic patients undergoing surgery |
PubMed
Title | Date | PubMed |
---|---|---|
Identification of an extracellular agent [correction of catalyst] of carbon tetrachloride dehalogenation from Pseudomonas stutzeri strain KC as pyridine-2, 6-bis(thiocarboxylate). | 1999 Aug 11 |
|
Characteristic hydrogen concentrations for various redox processes in batch study. | 2001 |
|
Prevention of caries by pulsed CO2 laser pre-treatment of enamel: an in-vitro study. | 2001 Dec |
|
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. | 2001 Feb |
|
A combined carbon dioxide/erbium laser for soft and hard tissue procedures. | 2001 Jan |
|
[Sinusoidal modulated currents alone and in combination with carbon dioxide-hydrogen sulfide baths in juvenile rheumatoid arthritis]. | 2001 Jul-Aug |
|
Resonance Raman studies of the iron(II)--alpha-keto acid chromophore in model and enzyme complexes. | 2001 May 30 |
|
Complete nucleotide sequence and organization of the atrazine catabolic plasmid pADP-1 from Pseudomonas sp. strain ADP. | 2001 Oct |
|
An indirect ELISA for detection of Encephalitozoon cuniculi infection in farmed blue foxes (Alopex lagopus). | 2002 |
|
Spontaneous disappearance of refractory viral warts at distant sites following carbon-dioxide laser treatment. | 2002 Dec |
|
Benzothiazole degradation by Rhodococcus pyridinovorans strain PA: evidence of a catechol 1,2-dioxygenase activity. | 2002 Dec |
|
Salivary cortisol concentrations before and after carbon-dioxide inhalations in children. | 2002 Feb 15 |
|
HPV in "carcinoma in situ" associated with HIV/AIDS infection: a case report. | 2002 Mar-Apr |
|
Chemical inactivation of the cinnamate 4-hydroxylase allows for the accumulation of salicylic acid in elicited cells. | 2002 Oct |
|
Site of nucleophilic attack and ring opening of five-membered heterocyclic 2,3-diones: a density functional theory study. | 2002 Oct 18 |
|
Induction of carbofuran oxidation to 4-hydroxycarbofuran by Pseudomonas sp. 50432. | 2002 Sep 10 |
|
Pheophytin-protein interactions in photosystem II studied by resonance Raman spectroscopy of modified reaction centers. | 2002 Sep 24 |
|
[Comparative estimation of effectiveness of nonsteroidal anti-inflammatory drugs used for postoperative pain management]. | 2003 |
|
Acoustic attenuation in gas mixtures with nitrogen: experimental data and calculations. | 2003 Apr |
|
Applications of laser-based ultrasonics to the characterization of the internal structure of teeth. | 2003 Jul |
|
[Effect of premedication on the formation of postoperative pain syndrome]. | 2003 Jul-Aug |
|
Identification of intramembrane hydrogen bonding between 13(1) keto group of bacteriochlorophyll and serine residue alpha27 in the LH2 light-harvesting complex. | 2003 Oct 17 |
|
Carbon-dioxide laser-assisted tonsil ablation for adults with chronic tonsillitis: a 6-month follow-up study. | 2003 Sep |
|
Energy cost and cardiorespiratory changes during the practice of Surya Namaskar. | 2004 Apr |
|
Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. | 2004 Dec |
|
Dynamic co-evolution of peptides and chemical energetics, a gateway to the emergence of homochirality and the catalytic activity of peptides. | 2004 Feb |
|
Lack of difference in the rates of hypopigmentation with 90-microsecond pulsed and longer dwell time carbon-dioxide laser resurfacing. | 2004 Feb |
|
CO2, not HCO3-, facilitates oxidations by Cu,Zn superoxide dismutase plus H2O2. | 2004 Jan 20 |
|
Supercritical carbon dioxide extraction of selected medicinal plants--effects of high pressure and added ethanol on yield of extracted substances. | 2004 Jan-Feb |
|
Influence of the organophosphorus insecticide phosphamidon on lentic water. | 2004 Jul |
|
Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. | 2004 Jul |
|
Supercritical carbon dioxide extraction of chamomile flowers: extraction efficiency, stability, and in-line inclusion of chamomile-carbon dioxide extract in beta-cyclodextrin. | 2004 Jul-Aug |
|
Direct determination of carbon dioxide in aqueous solution using mid-infrared quantum cascade lasers. | 2004 Jun |
|
Enzymatic reactions in anaerobic 2-methylnaphthalene degradation by the sulphate-reducing enrichment culture N 47. | 2004 Nov 1 |
|
Meerwein-Ponndorf-Verley alkynylation of aldehydes: essential modification of aluminium alkoxides for rate acceleration and asymmetric synthesis. | 2004 Nov 21 |
|
Metabolism of 2-mercaptobenzothiazole by Rhodococcus rhodochrous. | 2004 Oct |
|
Photochemical preparation of highly functionalized 1-indanones. | 2004 Oct 29 |
|
Difference between diabetic and nondiabetic smokers in the pituitary response to physical exercise. | 2004 Sep |
|
Retention characteristics of porous graphitic carbon in subcritical fluid chromatography with carbon dioxide-methanol mobile phases. | 2004 Sep 3 |
|
Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model. | 2005 |
|
Coupling aggressive mass removal with microbial reductive dechlorination for remediation of DNAPL source zones: a review and assessment. | 2005 Apr |
|
Metabolism of the aliphatic nitramine 4-nitro-2,4-diazabutanal by Methylobacterium sp. strain JS178. | 2005 Aug |
|
Optical-fiber-to-waveguide coupling using carbon-dioxide-laser-induced long-period fiber gratings. | 2005 Aug 15 |
|
Angiokeratoma circumscriptum naeviforme: successful treatment with carbon-dioxide laser vaporization. | 2005 Feb |
|
Strong effects of an individual water molecule on the rate of light-driven charge separation in the Rhodobacter sphaeroides reaction center. | 2005 Jul 22 |
|
Physico-chemical characteristics of Anopheles culicifacies and Anopheles varuna breeding water in a dry zone stream in Sri Lanka. | 2005 Jun |
|
Identification of 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid, 4-hydroxy-2-oxohexanoic acid, and 2-hydroxyhexa-2,4-dienoic acid and related enzymes involved in testosterone degradation in Comamonas testosteroni TA441. | 2005 Sep |
|
Differentiation of human bone marrow stem cells into cells with a neural phenotype: diverse effects of two specific treatments. | 2006 Feb 16 |
|
Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice. | 2006 Mar |
|
Characterisation of stationary phases in subcritical fluid chromatography with the solvation parameter model. III. Polar stationary phases. | 2006 Mar 31 |
Patents
Sample Use Guides
Carbon dioxide is usually administered through the lungs by inhalation. The major exceptions are when a metered supply is fed into the oxygenator of an extracorporeal circulation of a cardiopulmonary bypass system, and when the gas is used for laparoscopic surgery. As an additive to beverages, carbon dioxide is consumed orally.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:39:24 GMT 2023
by
admin
on
Fri Dec 15 15:39:24 GMT 2023
|
Record UNII |
142M471B3J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
16551-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13538-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
59165-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
28644-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
NDF-RT |
N0000180185
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14640-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
51781-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39465-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
77143-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
NDF-RT |
N0000010258
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2021-4
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2020-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
35685-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13541-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
41647-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2018-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2028-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39464-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
32306-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
JECFA EVALUATION |
INS-290
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-ATC |
A06AX02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
19212-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CFR |
21 CFR 862.1160
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
39466-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-290
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
28645-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57920-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53089-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
34520-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
48391-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2022-2
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
EPA PESTICIDE CODE |
16601
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2027-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
13540-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
11557-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
38253-1
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-VATC |
QA06AX02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
34728-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14040-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57922-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
FDA ORPHAN DRUG |
465114
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57923-5
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2026-3
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
20565-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
DSLD |
3848 (Number of products:1)
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53458-6
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
57921-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
53090-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2019-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
19223-7
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
CFR |
21 CFR 184.1240
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
2023-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-VATC |
QV03AN02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
11211-0
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
LOINC |
14003-8
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
||
|
WHO-ATC |
V03AN02
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4256
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
100000076280
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
DB09157
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
124-38-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
DTXSID4027028
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
m3079
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
516
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL1231871
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
CARBON DIOXIDE
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
142M471B3J
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
280
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
D002245
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
C65288
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
2034
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB13243MIG
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
16526
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY | |||
|
204-696-9
Created by
admin on Fri Dec 15 15:39:24 GMT 2023 , Edited by admin on Fri Dec 15 15:39:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CARBON DIOXIDE (% Vol.)
Non-filtered cigarette(85 mm) Univ Kentucky- 9.4 Filtered cigarette(85 mm) New Yorl City- 9.6 Little cigars A(85 mm) Boston-8.5 Little cigars B (85 mm),New York City-13.2 Small cigars C(95 mm),New York City-12.7
|
||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
Unit: percent of total dose excreted (into Expired Air; 39.7% to 58.6%)
IN-VIVO
|
||
|
PARENT -> METABOLITE |
MAJOR
EXHALATION
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |